Boston Science Corp. is transforming lives through innovative medical solutions that improve the health of patients around the world. As the world leader in the development of medical technology for more than 35 years, the company uses scientific advances to improve the quality of life, offering a wide range of highly effective solutions that meet the unrealized patient needs and reduce the cost of treatment. For more information, visit www.bostonscientific.eu, the news feed on Twitter (@bostonsci) and Facebook.
Briefly about the main figures (all indicators as of 2016):
•1 of the world's largest manufacturers of medical products
•13,000 medical products that change lives
•Commitment to innovation: 93 new medical products were launched, 19,000 patents were received worldwide, another 6,000 patents are pending
•Investments in R & D and clinical medicine amounting to $ 900 million annually
•The company's developments are used to treat 24 million patients annually
•135 clinical trials are underway
•The presence in the market in about 100 countries, 50 of which are located in Europe
•More than 27,000 employees in 40 offices around the world
•About 1,700 employees in 18 European offices
•13 production sites around the world, 3 of which are located in Europe
For over 35 years, Boston Scientific has been working on improving low-invasive medical technologies and offering a wide range of innovative products, technologies and services for this purpose.
The portfolio of Daksmed Group of Companies includes Boston Scientific products for Peripheral Angioplasty and Embolotherapy